FR2427331B2 - - Google Patents

Info

Publication number
FR2427331B2
FR2427331B2 FR7913823A FR7913823A FR2427331B2 FR 2427331 B2 FR2427331 B2 FR 2427331B2 FR 7913823 A FR7913823 A FR 7913823A FR 7913823 A FR7913823 A FR 7913823A FR 2427331 B2 FR2427331 B2 FR 2427331B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7913823A
Other languages
French (fr)
Other versions
FR2427331A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2427331A2 publication Critical patent/FR2427331A2/fr
Application granted granted Critical
Publication of FR2427331B2 publication Critical patent/FR2427331B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7913823A 1978-05-31 1979-05-30 Derives de l'hydantoine et medicaments contenant ces substances Granted FR2427331A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25575/78A GB1599740A (en) 1978-05-31 1978-05-31 Hydantoin derivatives

Publications (2)

Publication Number Publication Date
FR2427331A2 FR2427331A2 (fr) 1979-12-28
FR2427331B2 true FR2427331B2 (da) 1983-01-28

Family

ID=10229898

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913823A Granted FR2427331A2 (fr) 1978-05-31 1979-05-30 Derives de l'hydantoine et medicaments contenant ces substances

Country Status (11)

Country Link
JP (1) JPS554371A (da)
AU (1) AU4762579A (da)
BE (1) BE876670R (da)
DE (1) DE2922070A1 (da)
FR (1) FR2427331A2 (da)
GB (1) GB1599740A (da)
IL (1) IL57436A0 (da)
IT (1) IT1164693B (da)
NL (1) NL7904311A (da)
SE (1) SE7904700L (da)
ZA (1) ZA787354B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413002A (en) 1979-01-18 1983-11-01 Beecham Group Limited Bronchodilating hydantoin derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019223A1 (en) * 1979-05-09 1980-11-26 The Wellcome Foundation Limited Optically active hydantoin derivatives, their synthesis, pharmaceutical formulations containing them, and intermediates
EP0023083A1 (en) * 1979-06-27 1981-01-28 Beecham Group Plc Oxodiazole derivatives, processes for their production and pharmaceutical composition containing them
US4908456A (en) * 1989-04-05 1990-03-13 Takatori Corporation Process for preparing methylolated hydantoins
CN1084792C (zh) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 高风温高炉热风炉空气、煤气预热方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7706064A (nl) * 1976-06-03 1977-12-06 Wellcome Found Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
DK391678A (da) * 1977-09-05 1979-03-06 Wellcome Found Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413002A (en) 1979-01-18 1983-11-01 Beecham Group Limited Bronchodilating hydantoin derivatives

Also Published As

Publication number Publication date
IL57436A0 (en) 1979-09-30
ZA787354B (en) 1980-08-27
SE7904700L (sv) 1979-12-01
BE876670R (fr) 1979-11-30
AU4762579A (en) 1979-11-22
GB1599740A (en) 1981-10-07
FR2427331A2 (fr) 1979-12-28
JPS554371A (en) 1980-01-12
DE2922070A1 (de) 1979-12-06
IT1164693B (it) 1987-04-15
IT7949253A0 (it) 1979-05-30
NL7904311A (nl) 1979-12-04

Similar Documents

Publication Publication Date Title
DE2931173C2 (da)
FR2414553B1 (da)
FR2415330B1 (da)
FR2415726B1 (da)
FR2427331B2 (da)
FR2416024B1 (da)
FR2415269B1 (da)
DK69078A (da)
FR2413905B3 (da)
BG26013A1 (da)
BG25974A1 (da)
BG25875A1 (da)
BG25874A1 (da)
BG25842A1 (da)
BG25889A1 (da)
BG25956A1 (da)
BG26759A1 (da)
BG26478A1 (da)
BG25843A1 (da)
BG26429A1 (da)
BG26022A1 (da)
BG26017A1 (da)
BG26015A1 (da)
BG26014A1 (da)
BG26006A1 (da)